FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1991-1993 June 24, 1999 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Neuroblastoma is a malignant tumor in children that arises from primordial neural-crest cells destined to populate the adrenal gland and sympathetic ganglia, hence its varied clinical presentation and course. It accounts for 8 to 10 percent of all childhood cancers and for 15 percent of cancer-related deaths in children.¹ The distinctive nature of this neoplasm lies in its remarkable ability to resolve spontaneously while also being notoriously aggressive in older children with metastatic disease. The challenge for research on neuroblastoma over the past decade has been to improve the clinician's ability to predict the risk of relapse for any given . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.